Page last updated: 2024-10-24

organic cyclic compound binding

Definition

Target type: molecularfunction

Binding to an organic cyclic compound, any molecular entity that contains carbon arranged in a cyclic molecular structure. [GOC:sjw, PMID:7583672]

Organic cyclic compound binding refers to the interaction of a molecule with a cyclic organic compound. Cyclic organic compounds are molecules that contain a closed ring structure, formed by three or more atoms, often including carbon, oxygen, nitrogen, or sulfur. These interactions are essential for various biological processes, including:
1. **Signal Transduction:** Cyclic compounds like cyclic nucleotides (cAMP, cGMP) act as second messengers, relaying signals from receptors to downstream effector proteins. They bind to specific proteins, altering their activity and mediating cellular responses.
2. **Enzyme Catalysis:** Many enzymes require the binding of specific cyclic compounds as cofactors or substrates. For instance, NAD+ (nicotinamide adenine dinucleotide) and FAD (flavin adenine dinucleotide), which are important electron carriers in metabolism, have cyclic structures.
3. **DNA and RNA Binding:** Cyclic compounds like purines and pyrimidines are the building blocks of DNA and RNA. These molecules form specific interactions with each other, stabilizing the double helix structure of DNA and RNA.
4. **Drug Targeting:** Many pharmaceuticals exploit the ability of cyclic compounds to bind to specific targets within the body. For example, antibiotics like penicillin target bacterial enzymes involved in cell wall synthesis, and anti-cancer drugs like cisplatin bind to DNA, inhibiting cell division.
5. **Cellular Structure:** Cyclic compounds contribute to the structure and stability of membranes and other cellular components. For example, phospholipids, which form the cell membrane, contain cyclic structures.
The binding of cyclic compounds can occur through various non-covalent interactions, including hydrogen bonding, van der Waals forces, hydrophobic interactions, and electrostatic interactions. The specific interactions and binding affinity depend on the chemical structure of the compound and the binding site on the target molecule. These interactions are often highly specific, enabling the recognition and regulation of specific biological processes.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Synaptic vesicular amine transporterA synaptic vesicular amine transporter that is encoded in the genome of cow. [OMA:Q27963, PRO:DNx]Bos taurus (cattle)
Monocarboxylate transporter 1A monocarboxylate transporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P53985]Homo sapiens (human)
Melatonin receptor type 1AA melatonin receptor type 1A that is encoded in the genome of human. [PRO:WCB, UniProtKB:P48039]Homo sapiens (human)

Compounds (33)

CompoundDefinitionClassesRoles
melatoninacetamides;
tryptamines
anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
methylbufotenin5-methoxy-N,N-dimethyltryptamine : A tryptamine alkaloid that is N,N-dimethyltryptamine substituted by a methoxy group at position 5.aromatic ether;
tertiary amino compound;
tryptamine alkaloid
hallucinogen;
plant metabolite
6-chloromelatoninacetamides
6-hydroxymelatonin6-hydroxymelatonin : A member of the class of tryptamines that is melatonin with a hydroxy group substituent at position 6.acetamides;
tryptamines
metabolite;
mouse metabolite
reserpinereserpine : An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.

Reserpine: An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.
alkaloid ester;
methyl ester;
yohimban alkaloid
adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
tetrabenazine9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one : A benzoquinolizine that is 1,2,3,4,4a,9,10,10a-octahydrophenanthrene in which the carbon at position 10a is replaced by a nitrogen and which is substituted by an isobutyl group at position 2, an oxo group at position 3, and methoxy groups at positions 6 and 7.benzoquinolizine;
cyclic ketone;
tertiary amino compound
catechin(+)-catechin : The (+)-enantiomer of catechin and a polyphenolic antioxidant plant metabolite.

catechin : Members of the class of hydroxyflavan that have a flavan-3-ol skeleton and its substituted derivatives.

Catechin: An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms.

rac-catechin : A racemate comprising equimolar amounts of (+)- and (-)-catechin
catechinantioxidant;
plant metabolite
4,4'-bisphenol f4,4'-bisphenol F: RN given refers to parent cpd

bisphenol F : A bisphenol that is methane in which two of the hydrogens have been replaced by 4-hydroxyphenyl groups.
bisphenol;
diarylmethane
environmental food contaminant;
xenoestrogen
reserpic acidreserpic acid: inhibitor of norepinephrine transport into chromaffin vesicle ghosts; RN given refers to (3beta,16beta,17alpha,18beta,20alpha)-isomer parent cpd; structure given in first sourceyohimban alkaloid
s20098acetamides
6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-onebeta-carbolines
2-iodomelatoninacetamides
luzindoleluzindole : A member of the class of indoles that is tryptamine in which one of the amino hydrogens is replaced by an acetyl group while the hydrogen at position 2 is replaced by a benzyl group.

luzindole: melatonin receptor antagonist; structure given in first source
acetamides;
indoles
melatonin receptor antagonist
2-bromomelatonin2-bromomelatonin: structure given in first source
5-methoxyluzindole
n-cyclopropylcarbonyl-2-(7-methoxy-1-naphthyl)ethylamineN-cyclopropylcarbonyl-2-(7-methoxy-1-naphthyl)ethylamine: a highly potent & selective melatoninergic agonist; structure given in first source
ramelteonramelteon: melatonin MT1/MT2 receptor agonistindanes
a-130a
auraptenaurapten: RN refers to (E)-isomer; structure given in first source

auraptene : A member of the class of coumarins that is umbelliferone in which the phenolic hydrogen has been replaced by a geranyl group. Ii is isolated from several edible fruits and vegetables and exhibits a variety of therapeutic properties.
coumarins;
monoterpenoid
antihypertensive agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
dopaminergic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
gamma-secretase modulator;
gastrointestinal drug;
hepatoprotective agent;
matrix metalloproteinase inhibitor;
neuroprotective agent;
plant metabolite;
PPARalpha agonist;
vulnerary
umbellipreninumbelliprenin: RN given refers to cpd with unspecified isomeric designationterpene lactone
ah 001AH 001: structure given in first source; a melatonin agonist
4-phenyl-2-propionamidotetraline4-phenyl-2-propionamidotetraline: melatonin receptor antagonist; structure in first sourcetetralins
2-phenylmelatoninphenylindole
iik7IIK7: structure in first source
5-methoxycarbonylamino-n-acetyltryptamine5-methoxycarbonylamino-N-acetyltryptamine: an mt1/MT2 receptor agonistacetamides
8-methoxy-2-propionamidotetralin8-methoxy-2-propionamidotetralin: enhances sperm hyperactivation via the MT1 receptortetralins
k 185
4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride
ar c155858AR C155858: an MCT1 inhibitor; structure in first source
azd3965AZD3965: a monocarboxylate transporter-1 inhibitor with antineoplastic activity; structure in first source
ucm 454
5-hydroxyethoxy-n-acetyltryptamine5-hydroxyethoxy-N-acetyltryptamine: structure in first source
4'-geranyloxyferulic acid4'-geranyloxyferulic acid: a colon cancer chemopreventive agent isolated from grapefruit skin; structure in first source